Xebio Holdings Co., Ltd. (8281.T) JPX

1,041.00

+10(+0.97%)

Updated at June 03 11:29AM

Currency In JPY

Valuation

Market Cap41.07B
Enterprise Value31.55B
P/E Ratio-19.92
PEG Ratio0.57
Price/Sales Ratio0.17
Price/Book Ratio0.36
Enterprise/Revenue0.13
Enterprise/EBITDA4.22

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin0.01

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue252.33B
Revenue/Share6,094.66
Gross Profit95.09B
EBITDA9.34B
Net Income-2.16B
Diluted EPS-52.27

Balance Sheet

Total Cash15.81B
Total Cash/Share381.82
Total Debt6.29B
Total Debt/Equity0.05
Current Ratio1.83
Book Value Per Share2,857.78

Price History

52-Week Change-8.84
52-Week High1,215
52-Week Low951
Moving Average 50 Days1,011.1
Moving Average 200 Days1,073.9

Statistics

Average Volume149,818
Shares Outstanding41.38M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate35
Trailing Annual Dividend Yield3.36
Payout Ratio0
Last Split Factor3:2
Last Split DateMarch 28, 2006